Get This Health Care Analyst’s Take On The Drug Pricing Debate And Biotech Picks For 2016
This week we are pleased to be joined by our friend Joe McCann, founder of Slingshot Insights. In this episode, Leigh and Joe weigh in on the current debate over inflated drug pricing (starts at 3:23), discuss updates to the Martin Shkreli story, the disgraced CEO of Turig Pharmaceuticals that kicked off this whole controversy (16:45), and we get Joe’s picks for biotech stocks to watch in 2016 (10:50).
Disclosure: There can be no assurance that the information we considered is accurate or complete, nor can there be any assurance that our assumptions are correct.
How did you like this article? Let us know so we can better customize your reading experience.
Comments
Leave a comment to automatically be entered into
our contest to win a free Echo Show.
